Literature DB >> 32419033

Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?

Chen-Lung Ku1,2, Chih-Yu Chi3,4, Horst von Bernuth5,6,7, Rainer Doffinger8,9.   

Abstract

Anti-cytokine autoantibodies may cause immunodeficiency and have been recently recognized as 'autoimmune phenocopies of primary immunodeficiencies' and are found in particular, but not exclusively in adult patients. By blocking the cytokine's biological function, patients with anti-cytokine autoantibodies may present with a similar clinical phenotype as the related inborn genetic disorders. So far, autoantibodies to interferon (IFN)-γ, GM-CSF, to a group of TH-17 cytokines and to IL-6 have been found to be causative or closely associated with susceptibility to infection. This review compares infectious diseases associated with anti-cytokine autoantibodies with primary immunodeficiencies affecting similar cytokines or related pathways.

Entities:  

Year:  2020        PMID: 32419033     DOI: 10.1007/s00439-020-02180-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

1.  Clinicopathological Manifestations and Immune Phenotypes in Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibodies.

Authors:  Yi-Chun Chen; Shao-Wen Weng; Jing-Ya Ding; Chen-Hsiang Lee; Cheng-Lung Ku; Wen-Chi Huang; Huey-Ling You; Wan-Ting Huang
Journal:  J Clin Immunol       Date:  2022-01-28       Impact factor: 8.317

2.  Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Authors:  Han-Po Shih; Jing-Ya Ding; Junel Sotolongo Bellón; Yu-Fang Lo; Pei-Han Chung; He-Ting Ting; Jhan-Jie Peng; Tsai-Yi Wu; Chia-Hao Lin; Chia-Chi Lo; You-Ning Lin; Chun-Fu Yeh; Jiun-Bo Chen; Ting-Shu Wu; Yuag-Meng Liu; Chen-Yen Kuo; Shang-Yu Wang; Kun-Hua Tu; Chau Yee Ng; Wei-Te Lei; Yu-Huan Tsai; Jou-Han Chen; Ya-Ting Chuang; Jing-Yi Huang; Félix A Rey; Hung-Kai Chen; Tse-Wen Chang; Jacob Piehler; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Exp Med       Date:  2022-07-14       Impact factor: 17.579

3.  Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.

Authors:  Shang-Yu Wang; Yu-Fang Lo; Han-Po Shih; Mao-Wang Ho; Chun-Fu Yeh; Jhan-Jie Peng; He-Ting Ting; Kuo-Hsi Lin; Wen-Chi Huang; Yi-Chun Chen; Yu-Hsin Chiu; Chien-Wei Hsu; Yu-Ting Tseng; Lih-Shinn Wang; Wei-Yi Lei; Chen-Yuan Lin; Yu Aoh; Chia-Huei Chou; Tsai-Yi Wu; Jing-Ya Ding; Chia-Chi Lo; You-Ning Lin; Kun-Hua Tu; Wei-Te Lei; Chen-Yen Kuo; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Clin Immunol       Date:  2022-08-10       Impact factor: 8.542

Review 4.  Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?

Authors:  Quentin Philippot; Jean-Laurent Casanova; Anne Puel
Journal:  Curr Opin Immunol       Date:  2021-08-26       Impact factor: 7.268

5.  Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections.

Authors:  Zhao-Ming Chen; Xiao-Yun Yang; Zheng-Tu Li; Wei-Jie Guan; Ye Qiu; Shao-Qiang Li; Yang-Qing Zhan; Zi-Ying Lei; Jing Liu; Jian-Quan Zhang; Zhong-Fang Wang; Feng Ye
Journal:  Infect Drug Resist       Date:  2022-06-28       Impact factor: 4.177

Review 6.  Human genetic and immunological determinants of critical COVID-19 pneumonia.

Authors:  Qian Zhang; Paul Bastard; Aurélie Cobat; Jean-Laurent Casanova
Journal:  Nature       Date:  2022-01-28       Impact factor: 69.504

Review 7.  Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity.

Authors:  Aristine Cheng; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2022-01       Impact factor: 14.290

Review 8.  Infection-induced inflammation from specific inborn errors of immunity to COVID-19.

Authors:  Cheng-Lung Ku; I-Ting Chen; Ming-Zong Lai
Journal:  FEBS J       Date:  2021-05-20       Impact factor: 5.622

9.  Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.

Authors:  Tanya Dorff; Yosuke Hirasawa; Jared Acoba; Ian Pagano; David Tamura; Sumanta Pal; Minlu Zhang; Rebecca Waitz; Abhilash Dhal; Winston Haynes; John Shon; Mark Scholz; Hideki Furuya; Owen T M Chan; Jeffrey Huang; Charles Rosser
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 10.  Mycobacterial diseases in patients with inborn errors of immunity.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante
Journal:  Curr Opin Immunol       Date:  2021-07-24       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.